Preoperative Treatment of Locally Advanced Rectal Cancer: Assets and Drawbacks of Short Course and Long Course in Clinical Practice

Seminars in Radiation Oncology

Volumn 26, Issue 3, 2016, Pages 186-192

  Ngan, Samuel Y ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADVANCED CANCER; ANUS SPHINCTER; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LONG TERM CARE; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION ONCOLOGIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECURRENCE FREE SURVIVAL; REVIEW; SHORT COURSE THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ADJUVANT RADIOTHERAPY; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; RECTUM TUMOR;

CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS;

EID: 84969813037     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2016.02.007     Document Type: Review

References (36)

1. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994, 331:502-507.
2. Sauer R., Becker H., Hohenberger P., et al. Preoperative chemoradiotherapy as compared with postoperative chemoradiotherapy for locally advanced rectal cancer. N Engl J Med 2004, 351:1731-1740.
3. Sauer R., Liersch T., Merkel S., et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012, 30:1926-1933.
4. Roh M.S., Colangelo L.H., O'Connell M.J., et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009, 27:5124-5130.
5. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
6. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy with rectal cancer. N Engl J Med 2006, 355:1114-1123.
7. Bosset J.F., Calais G., Mineur L., et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014, 15:184-190.
8. Swedish Rectal Cancer Trial: Improved survival with preoperative radio- therapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987.
9. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: Long-lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650.
10. MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460.
11. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
12. van Gijn W., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-Year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12:575-582.
13. Peeters K.C., Van De Velde C.J., Leer J.W., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients-A Dutch colorectal cancer group study. J Clin Oncol 2005, 23:6199-6206.
14. Marijnen C.A., Van De Velde C.J., Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2005, 23:1847-1858.
15. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009, 373:811-820.
16. Quirke P., Steele R., Monson J., et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009, 373:821-828.
17. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24.
18. Ngan S.Y., Burmeister B., Fisher R.J., et al. Randomized trial of short course radiotherapy versus long course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012, 30:3827-3833.
19. Siegel R., Burock S., Wernecke K.-D., et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: A multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 2009, 9:50.
20. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006, 93:1215-1223.
21. Pietrzak L., Bujko K., Nowacki M.P., et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial. Radiother Oncol 2007, 84:217-225.
22. Ngan S.Y.K., Fisher R., Burmeister B.H., et al. Promising results of a co-operative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum 2005, 48:1389-1396.
23. McLachlan S.A., Fisher R.J., Zalcberg J., et al. The impact on health-related quality of life in the first 12 months: A randomized comparison of pre-operative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04). Eur J Cancer 2016, 55:15-26.
24. Ngan S., Fisher R., Burmeister B., et al. Long-term quality of life in patients treated in TROG 01.04: A randomized trial comparing short course and long course preoperative radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2012, 84:S143-S144. (suppl).
25. Pettersson D., Holm T., Iversen H., et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010, 97:580-587.
26. Aschele C., Cionini L., Lonardi S., et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011, 29:2773-2780.
27. Rodel C., Graeven U., Fietkau R., et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2015, 16:979-989.
28. Gérard J.P., Azria D., Gourgou-Bourgade S., et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010, 28:1638-1644.
29. Schmoll H.-J., Haustermans K., Price T.J., et al. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial. J Clin Oncol 2013, 31. [suppl; abstr 3531].
30. Allegra C.J., Yothers G., O'Connell M.J., et al. Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: A phase III randomized clinical trial. J Natl Cancer Inst 2011, 107:djv248.
31. Willett C.G., Duda D.G., di Tomaso E., et al. Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: A multidisciplinary phase II study. J Clin Oncol 2009, 27:3020-3026.
32. Glynne-Jones R., Anyamene N., Moran B., et al. Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?. Ann Oncol 2012, 23:2517-2526.
33. Chua Y.J., Barbachano Y., Cunningham D., et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial. Lancet Oncol 2010, 11:241-248.
34. Ngan S., Bressel M., McClure B., et al. A phase II trial of integrated preoperative radiotherapy and chemotherapy with oxaliplatin 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer: Trans-Tasman Radiation Oncology Group TROG 09.01. Int J Radiat Oncol Biol Phys 2014, 90:S21-S22.
35. Maas M., Beets-Tan R.G.H., Lambregts D.M.J., et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011, 29:4633-4640.
36. Nilsson P.J., van Etten B., Hospers G.A., et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-The RAPIDO trial. BMC Cancer 2013, 13:279.